Camrelizumab, a patinib and radiotherapy in locally advanced, unresectable hepatocellular carcinoma: a phase 2 study.

AiTan (rivoceranib) - Elevar Therapeutics

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42377073

Baocai Xing; Dezuo Dong; Hongzhi Wang; Huajing Teng; Kun Wang; Weihu Wang; Xianggao Zhu; Xin Sui; Xuan Zheng

Jul 1, 2026